|
Match
|
Document |
Document Title |
|
|
US20090275660 |
STABLE PARENTERAL FORMULATIONS OF TIGECYCLINE
The present invention relates to stable parenteral formulations of tigecycline and process of preparation thereof, wherein the formulation comprises of an edetate, a pH modifying agent or an...
|
|
|
US20090170947 |
DISINFECTANT COMPOSITIONS, METHODS AND SYSTEMS
Disinfectant compositions comprising PHMB and EDTA salt(s) are disclosed. The disinfectant compositions have also demonstrated activity as enhanced, fast acting catheter lock/flush solutions. They...
|
|
|
US20090149541 |
Method of delaying the onset of clinically definite multiple sclerosis
A method for delaying the onset of clinically definite multiple sclerosis in a patient at risk of developing clinically definite multiple sclerosis and retard long-term progression of multiple...
|
|
|
US20090092575 |
OPHTHALMIC COMPOSITIONS WITH A DISUCCINATE
The invention is directed to an ophthalmic composition comprising a disuccinate of formula I or a corresponding salt thereof;
wherein R 1 is selected from hydrogen, alkyl or —C(O)alkyl, the...
|
|
|
US20090030081 |
USE OF LR-90 AND LR-102 TO OVERCOME INSULIN RESISTANCE
The present invention provides methods for ameliorating, overcoming, or inhibiting insulin resistance in a subject, comprising administering to the subject an effective amount of a compound...
|
|
|
US20080312195 |
Preservatives
The invention relates to clear, liquid preservatives, which contain a) one or several 1-hydroxy-4-methyl-6-alkyl-2(1H)-pyridones and/or one or several salts thereof. wherein alkyl represents a...
|
|
|
US20080176821 |
LIGANDS FOR METABOTROPIC GLUTAMATE RECEPTORS AND INHIBITORS OF NAALADASE
The present invention relates to novel compounds and formulations thereof which compounds are ligands, e.g., agonists or antagonists, for a metabotropic glutamate receptor or a NAALADase enzyme or...
|
|
|
US20080153889 |
Compositions and Methods for the Treatment of Renal and Cardiovascular Disease
Derivative compounds of 11-nonyloxy-undec- 8 (Z)-eonic acid that mimic epoxide metabolites are provided. Also provided are compositions comprising a therapeutically effective amount of the...
|
|
|
US20080153913 |
Nutritional Supplement and Protocol
Particular nutritional supplements and protocols emphasize the use of ethylenediamine tetraacetic acid as a mouth rinse, and as an enteric-coated oral pharmaceutical, further supplemented on a...
|
|
|
US20080108684 |
THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASE AND TNF-ALFA PRODUCTION INHIBITOR
Disclosed is an agent for use in the treatment or prevention of inflammatory bowel disease. Also disclosed is an agent for inhibiting the production of TNF-α. A therapeutic or prophylactic agent...
|
|
|
US20080085331 |
Composition and method for raising blood glucose level
Composition, non-aerosol dispenser containing the composition, and method of raising the blood glucose level of an individual comprising administering an effective amount of the composition to an...
|
|
|
US20080039365 |
Rapid Acting and Long Acting Insulin Combination Formulations
A combined rapid acting-long acting insulin formulation has been developed wherein the pH of the rapid acting insulin is decreased so that the long acting glargine remains soluble when they are...
|